Clinical Trial Update: Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating single-dose liposomal amphotericin for asymptomatic cryptococcal antigenemia related to cryptococcal meningitis is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis

Drugs mentioned

• liposomal amphotericin (liposomal amphotericin)

Snippet

Sponsor: Makerere University | Conditions: Cryptococcal Meningitis | Phase 2, Phase 3 | Status: RECRUITING